tradmap

RSI Oversold Bounce Stocks — Valuation View · Healthcare

27 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Valuation columns. Filtered to Healthcare. Updated

Filters2
1–27 of 27
PRVAPrivia Health Group, Inc.$2.6B93.921.123.386.4120.68-0.29%61K
ESTAEstablishment Labs Holdings Inc.$2.2B-55.448.7799.7930.3072.35-3.60%20K
EYENational Vision Holdings, Inc.$1.3B26.530.661.4937.0516.87+0.42%81K
GLUEMonte Rosa Therapeutics, Inc.$1.2B-7.622.5213.6214.39+1.12%38K
AHCOAdapthealth Corp.$878M-3.850.270.6418.316.44+6.45%196K
GRMLGreenland Mines Ltd$715M-32.8412.3576.864.50-7.31%22K
TCMDTACTILE SYSTEMS TECHNOLOGY INC$498M20.021.422.227.1321.98-2.01%9K
RLMDRelmada Therapeutics, Inc.$467M-7.5429945.772.2641.224.38-3.74%68K
EYPTEyepoint, Inc.$394M-1.282.373.574.57-4.39%120K
ELDNEledon Pharmaceuticals, Inc.$237M-2.417.1934.882.92-2.34%101K
INGNInogen Inc$144M-5.870.480.831.655.44+0.93%17K
HYPRHyperfine, Inc.$82M-2.372.241.900.83+3.61%11K
CALCCalciMedica, Inc.$75M-3.5413.664.042.21+5.00%192
VBIOValion Bio, Inc.$62M-3.3179.6614.6329.472.80-10.26%174
SCLXScilex Holding Co$45M-0.101.4379.685.31-0.56%2K
CNTXContext Therapeutics Inc.$33M-0.720.860.770.36-2.32%28K
BCHTBirchtech Corp.$31M-10.261.623.812.621.18-0.84%546
IRIXIRIDEX CORP$12M-2.820.243.432.670.71-1.51%566
KALAKALA BIO, Inc.$11M-1.061.1846.470.55+4.34%8K
PMCBPharmaCyte Biotech, Inc.$5M-0.330.190.300.49+1.62%800
TCRTAlaunos Therapeutics, Inc.$4M-1.041393.036.4133.701.65+1.54%2
VIVSVivoSim Labs, INC.$4M-0.3031.252.450.28-1.01%8K
SILOSilo Pharma, Inc.$4M-0.8671.370.791.182.43-5.26%200
RADXRadiopharm Theranostics Ltd2.09+1.95%76
INDVIndivior Pharmaceuticals, Inc.34.84-0.56%124K
BYSIBeyondSpring Inc.0.64+3.12%200
VRXAVeraxa Biotech AG - Post de-SPAC1.80+16.88%37K

Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.